NAD+ (Nicotinamide Adenine Dinucleotide): Mechanism, Research, and Applications

NAD+ anchors the metabolic foundation of the Kinetic Compounds Longevity research area. Unlike the mitochondrial peptides SS-31 and MOTS-c or the bioregulator Epitalon, NAD+ is not a peptide at all — it is a small-molecule coenzyme that every cell depends on to convert nutrients into usable energy. Its research significance comes from a striking observation: NAD+ levels fall with age, and that decline is mechanistically tied to many of the hallmarks of aging, which has made restoring NAD+ one of the most active areas in longevity science.

This article addresses NAD+ as a research compound: its identity as an essential redox coenzyme, the mechanisms by which it powers metabolism and serves as a substrate for sirtuins and PARPs, the research applications spanning aging and mitochondrial function, and the handling and sourcing considerations researchers should understand before working with the compound.

What Is NAD+?

NAD+ (nicotinamide adenine dinucleotide) is an essential coenzyme found in every living cell, with a molecular weight of approximately 663 g/mol. It is important to note that NAD+ is a small-molecule dinucleotide, not a peptide — though it is often grouped with research peptides in longevity contexts.

NAD+ exists in two interconverting forms: the oxidized form (NAD+) and the reduced form (NADH). This pair shuttles electrons between metabolic reactions, which is the basis of NAD+’s role as the cell’s central energy-currency cofactor [Ref. 3].

NAD+ availability declines with age, reducing the activity of NAD+-dependent enzymes and impairing communication between the cell nucleus and its mitochondria. This age-related decline is associated with reduced metabolic capacity and is implicated in cognitive decline, sarcopenia, and metabolic disease [Ref. 5].

NAD+ is a naturally occurring coenzyme rather than an approved pharmaceutical. It has not been approved by FDA, Health Canada, EMA, MHRA, or any other Western regulatory agency as a drug for anti-aging or related uses. Research-grade NAD+ sold for laboratory research is intended exclusively for that purpose.

Mechanism of Action

NAD+ acts through two broad roles: as a redox cofactor in metabolism, and as a consumable substrate for a set of regulatory enzymes.

Redox cofactor in energy metabolism. NAD+ mediates electron-transfer (redox) reactions by cycling between NAD+ and NADH, supporting the core energy-producing pathways — glycolysis, fatty-acid (beta) oxidation, and oxidative phosphorylation in the mitochondria [Ref. 3]. Without adequate NAD+, the cell’s capacity to generate ATP is constrained.

Substrate for sirtuins. NAD+ is the required substrate for the sirtuins, a family of enzymes that remove acyl groups from proteins to regulate gene expression, stress responses, and metabolism. The coupling of NAD+ breakdown to sirtuin activity is the mechanistic link that translates energy status into the regulation of aging and longevity [Ref. 1].

Substrate for PARPs and DNA repair. NAD+ is also consumed by poly(ADP-ribose) polymerases (PARPs) during DNA repair. PARP activation in response to DNA damage can consume large amounts of NAD+, creating competition for the limited NAD+ pool between DNA repair, sirtuins, and other NAD+-consuming enzymes such as CD38 [Ref. 2].

NAD+ decline and mitochondrial communication. Because sirtuins (particularly mitochondrial sirtuins) depend on NAD+, falling NAD+ with age reduces sirtuin activity and disrupts nucleus-to-mitochondria signaling — a pathway central to age-related mitochondrial dysfunction [Ref. 1][Ref. 5].

Compound distinction. NAD+ is a foundational metabolic cofactor rather than a receptor-targeting compound; it complements mitochondria-targeting peptides such as SS-31 (which stabilizes the inner membrane) and MOTS-c (a mitochondrial-derived signaling peptide) by addressing the cell’s underlying energy-cofactor supply.

Research Applications

NAD+ research is concentrated in aging biology and metabolism, supported by a large and growing clinical literature on NAD+ and its precursors.

Aging and longevity. The central domain. Interventions that raise NAD+ levels have extended lifespan in worms and mice, and NAD+ decline is tied to multiple hallmarks of aging, making NAD+ restoration a major longevity research focus [Ref. 1][Ref. 2].

Mitochondrial function. NAD+ metabolism is closely linked to mitochondrial health; NAD+ decline parallels mitochondrial dysfunction across tissues, and NAD+ modulation is studied in mitochondrial and age-related disorders [Ref. 2].

NAD+ precursors (NMN and NR). Much human research uses NAD+ precursors — nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) — which raise NAD+ levels. Systematic review of clinical studies indicates oral NMN/NR is generally safe and well tolerated at the doses studied [Ref. 4].

Broader research domains. NAD+ and its metabolism have additionally been studied across:

• Neurodegeneration and cognitive-decline models
• Metabolic disease and insulin sensitivity
• Muscle aging and sarcopenia
• DNA-repair and cellular-stress research

Across all research domains, research-grade NAD+ is intended for laboratory research only in the Kinetic Compounds context. The compound has not been evaluated by FDA, Health Canada, or any other Western regulatory agency as a therapeutic.

Forms and Research Handling

NAD+ for research is supplied as a lyophilized powder or solution. Where lyophilized, it is reconstituted with bacteriostatic water following the standard concentration-equals-mass-divided-by-volume principle in our reconstitution tutorial; a 100 mg vial in 2 mL yields 50 mg/mL. Researchers can verify their math against our peptide reconstitution calculator. Note that NAD+ precursors such as NMN and NR are typically studied as oral compounds rather than reconstituted injectables.

This article does not provide dosing guidance for any therapeutic purpose. Research-grade NAD+ is intended for laboratory research only.

Storage & Handling

Lyophilized NAD+ should be stored cool and dry, protected from light, with long-term storage at -20°C (-4°F) on receipt. NAD+ is sensitive to moisture and heat, so minimizing exposure is important. Once in solution, NAD+ should be refrigerated at 2–8°C and used promptly. See our storage and stability guide for detailed protocols.

Any solution should be visually inspected before use; cloudiness, discoloration, or visible sediment indicates degradation and the product should not be used in research.

Sourcing Verified NAD+ for Research

As a defined small molecule, NAD+ is verified by HPLC for purity and mass spectrometry confirming the expected ~663 Da mass. Because NAD+ degrades with moisture and heat, batch freshness and proper handling are as important as initial purity.

A credible Certificate of Analysis for NAD+ should show HPLC purity expressed as a percentage and mass spectrometry confirmation. The principles of reading a research COA are covered in detail in our reading a Certificate of Analysis article, and our specific third-party testing methodology is documented in our Janoshik Analytical methodology article.

Kinetic Compounds tests every batch of NAD+ through Janoshik Analytical, an independent third-party laboratory. Current batch reports are published on the NAD+ product page. Our broader testing methodology is documented on our lab testing and COA page.

For researchers working across the broader longevity and mitochondrial research area, SS-31, MOTS-c, and Epitalon are mechanistically distinct but complementary research compounds in the Kinetic Compounds catalog. The full research peptide catalog is available through our shop.